These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Association of VEGF and KDR single nucleotide polymorphisms with colorectal cancer susceptibility in Koreans. Jang MJ, Jeon YJ, Kim JW, Cho YK, Lee SK, Hwang SG, Oh D, Kim NK. Mol Carcinog; 2013 Nov; 52 Suppl 1():E60-9. PubMed ID: 23169005 [Abstract] [Full Text] [Related]
4. Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcome. Eng L, Azad AK, Qiu X, Kong QQ, Cheng D, Ying N, Tse A, Kuang Q, Dodbiba L, Renouf DJ, Marsh S, Savas S, Mackay HJ, Knox JJ, Darling GE, Wong RK, Xu W, Liu G, Faluyi OO. Carcinogenesis; 2015 Sep; 36(9):956-62. PubMed ID: 26014353 [Abstract] [Full Text] [Related]
5. Both Kdr and Flt1 play a vital role in hypoxia-induced Src-PLD1-PKCγ-cPLA(2) activation and retinal neovascularization. Singh NK, Hansen DE, Kundumani-Sridharan V, Rao GN. Blood; 2013 Mar 07; 121(10):1911-23. PubMed ID: 23319572 [Abstract] [Full Text] [Related]
6. Single-nucleotide polymorphisms in the vascular endothelial growth factor pathway and outcomes of patients treated with first-line cytotoxic chemotherapy combined with bevacizumab for advanced colorectal cancer. Sohn BS, Park SJ, Kim JE, Kim KP, Hong YS, Suh C, Kim YS, Kim SY, Im SA, Kim SY, Kim JH, Ahn JB, Park YS, Kim TW. Oncology; 2014 Mar 07; 87(5):280-92. PubMed ID: 25139485 [Abstract] [Full Text] [Related]
9. A pathway approach to evaluating the association between the CHIEF pathway and risk of colorectal cancer. Slattery ML, Wolff RK, Lundgreen A. Carcinogenesis; 2015 Jan 07; 36(1):49-59. PubMed ID: 25330801 [Abstract] [Full Text] [Related]
13. Activated VEGFR2/KDR pathway in tumour cells and tumour associated vessels of colorectal cancer. Giatromanolaki A, Koukourakis MI, Sivridis E, Chlouverakis G, Vourvouhaki E, Turley H, Harris AL, Gatter KC. Eur J Clin Invest; 2007 Nov 07; 37(11):878-86. PubMed ID: 17883421 [Abstract] [Full Text] [Related]
14. Association of polymorphisms/haplotypes of the genes encoding vascular endothelial growth factor and its KDR receptor with recurrent pregnancy loss. Su MT, Lin SH, Lee IW, Chen YC, Kuo PL. Hum Reprod; 2011 Apr 07; 26(4):758-64. PubMed ID: 21257617 [Abstract] [Full Text] [Related]
16. Genetic variation in VEGF family genes and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study. Beeghly-Fadiel A, Shu XO, Lu W, Long J, Cai Q, Xiang YB, Zheng Y, Zhao Z, Gu K, Gao YT, Zheng W. Cancer Epidemiol Biomarkers Prev; 2011 Jan 07; 20(1):33-41. PubMed ID: 21119072 [Abstract] [Full Text] [Related]
17. Associations of VEGFA and KDR single-nucleotide polymorphisms and increased risk and aggressiveness of high-grade gliomas. Vasconcelos VCA, Lourenço GJ, Brito ABC, Vasconcelos VL, Maldaun MVC, Tedeschi H, Marie SKN, Shinjo SMO, Lima CSP. Tumour Biol; 2019 Sep 07; 41(9):1010428319872092. PubMed ID: 31486713 [Abstract] [Full Text] [Related]
18. [Expression of vascular endothelial growth factor and its receptors KDR and Flt1 in acute myeloid leukemia]. Wang Y, Xiao ZJ, Liu P, Yang C, Yang RC, Cai YL, Han ZC. Zhonghua Xue Ye Xue Za Zhi; 2003 May 07; 24(5):249-52. PubMed ID: 12859876 [Abstract] [Full Text] [Related]